Estrogen-progesterone combo raises breast cancer risk

03/19/2009 | Medscape (free registration)

A report from the American Cancer Society found the combined use of estrogen and progesterone in postmenopausal women more than doubles the risk of lobular breast cancer and almost doubles the risk of ductal breast cancer. Researchers found the risk began to decrease two years after discontinuing the drugs. Estrogen alone did not increase the risks of cancer, the report found.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY